TDAC

Translational Development Acquisition
$10.74
+$0.01 (+0.05%)Jul 27, 2026
3.6FairMoatMint rating

MoatMint rates Translational Development Acquisition (TDAC) 3.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.2 out of 10.

Key metrics

The numbers that frame TDAC today
Market cap
$235.29M
P/E (TTM)
37.9
EV / FCF
-345.7
ROIC
3.4%
Div yield
0%
52wk Low
$10.32
52wk High
$10.80

TDAC stock rating

How TDAC scores on quality, value, growth, momentum and financial health
3.6out of 10
Fair overallNeutral business, full priceTop 64% of ~5,000 US stocks
QualityFair3.2/10
GrowthFair2.8/10
MomentumNeutral5.2/10
ValueNeutral4.9/10
Financial HealthGood6.5/10

Growth

Revenue and earnings trend for TDAC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TDAC
Is Translational Development Acquisition a good buy?
Hold. Translational Development Acquisition has weak quality and mixed momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Translational Development Acquisition is selling at a fair price.
What is the market capitalization of TDAC?
Translational Development Acquisition's market capitalization is $235.29M.
What is the P/E ratio for TDAC stock?
Translational Development Acquisition's current P/E ratio is 37.9.
What is the 52-week high for TDAC stock?
The 52-week high for Translational Development Acquisition is $10.80. The current close of $10.74 is 0.6% below that high.
What is the 52-week low for TDAC stock?
The 52-week low for Translational Development Acquisition is $10.32. The current close of $10.74 is 4.1% above that low.
Does TDAC stock pay dividends?
Translational Development Acquisition does not currently show a dividend per share in the company data.